Two new DRY POWDER inhalers will soon hit the market
Two new DRY POWDER inhalers will soon hit the market...Glaxo's Flovent Rotadisk and Serevent Diskus.
These have been developed as an alternative to aerosol MDIs...because of the upcoming ban on chlorofluorocarbon propellants.
Now the big challenge will be teaching patients how to use these new dry powder inhalers.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote